BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7462634)

  • 1. Interaction of C-reactive protein with liposomes. III. Membrane requirements for binding.
    Mold C; Rodgers CP; Richards RL; Alving CR; Gewurz H
    J Immunol; 1981 Mar; 126(3):856-60. PubMed ID: 7462634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of C-reactive protein and complement with liposomes. II. Influence of membrane composition.
    Richards RL; Gewurz H; Siegel J; Alving CR
    J Immunol; 1979 Apr; 122(4):1185-9. PubMed ID: 448084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement.
    Volanakis JE; Narkates AJ
    J Immunol; 1981 May; 126(5):1820-5. PubMed ID: 7217669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes.
    Li YP; Mold C; Du Clos TW
    J Immunol; 1994 Mar; 152(6):2995-3005. PubMed ID: 8144898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of C-reactive protein on alternative C pathway activation by liposomes and Streptococcus pneumoniae.
    Mold C; Gewurz H
    J Immunol; 1981 Nov; 127(5):2089-92. PubMed ID: 6913608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of human C-reactive protein with positively charged liposomes.
    Tsujimoto M; Inoue K; Nojima S
    J Biochem; 1981 Nov; 90(5):1507-14. PubMed ID: 7338519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation by interaction of polyanions and polycations. III. Complement activation by interaction of multiple polyanious and polycations is the presence of C-reactive protein.
    Claus DR; Siegel J; Petras K; Skor D; Osmand AP; Gewurz H
    J Immunol; 1977 Jan; 118(1):83-7. PubMed ID: 830761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein inhibits in vitro oxidation of low-density lipoprotein.
    Rufail ML; Ramage SC; van Antwerpen R
    FEBS Lett; 2006 Oct; 580(22):5155-60. PubMed ID: 16962105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of the binding of human C-reactive protein (CRP) to laminin.
    Swanson SJ; McPeek MM; Mortensen RF
    J Cell Biochem; 1989 May; 40(1):121-32. PubMed ID: 2745572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in permeability of liposomal membranes mediated by C-reactive protein and its inhibition by cholesterol.
    Ohsawa T
    Jpn J Exp Med; 1980 Feb; 50(1):67-71. PubMed ID: 7382134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of human serum amyloid P-component to phosphocholine.
    Christner RB; Mortensen RF
    Arch Biochem Biophys; 1994 Nov; 314(2):337-43. PubMed ID: 7979374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of histone H1 with phospholipids and comparison of its binding to giant liposomes and human leukemic T cells.
    Zhao H; Bose S; Tuominen EK; Kinnunen PK
    Biochemistry; 2004 Aug; 43(31):10192-202. PubMed ID: 15287747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultraviolet irradiation of diacetylenic liposomes as a strategy to improve size stability and to alter protein binding without cytotoxicity enhancement.
    Temprana CF; Amor MS; Femia AL; Gasparri J; Taira MC; del Valle Alonso S
    J Liposome Res; 2011 Jun; 21(2):141-50. PubMed ID: 20560742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of C-reactive protein to human lymphocytes. I. Requirement for a binding specificity.
    James K; Hansen B; Gewurz H
    J Immunol; 1981 Dec; 127(6):2539-44. PubMed ID: 7028874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol-dependent human complement activation resulting in damage to liposomal model membranes.
    Alving CR; Richards RL; Guirguis AA
    J Immunol; 1977 Jan; 118(1):342-7. PubMed ID: 830757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of very low density lipoproteins (VLDL) with rabbit C-reactive protein.
    Cabana VG; Gewurz H; Siegel JN
    J Immunol; 1982 May; 128(5):2342-8. PubMed ID: 6801137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of cholesterol on the interaction of alpha-crystallin with phospholipids.
    Tang D; Borchman D; Yappert MC; Cenedella RJ
    Exp Eye Res; 1998 May; 66(5):559-67. PubMed ID: 9628803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESR studies on the effect of cholesterol on chlorpromazine interaction with saturated and unsaturated liposome membranes.
    Wisniewska A; Wolnicka-Glubisz A
    Biophys Chem; 2004 Sep; 111(1):43-52. PubMed ID: 15450374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding reactivity of C-reactive protein for polycations. II. Modulatory effects of calcium and phosphocholine.
    Potempa LA; Siegel JN; Gewurz H
    J Immunol; 1981 Oct; 127(4):1509-14. PubMed ID: 7276568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein and annexin A5 bind to distinct sites of negatively charged phospholipids present in oxidized low-density lipoprotein.
    van Tits L; de Graaf J; Toenhake H; van Heerde W; Stalenhoef A
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):717-22. PubMed ID: 15692104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.